F Turpin

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.

M. Spielmann, Thierry Dorval, F Turpin et al. · Journal of Clinical Oncology · 1994 · 102 citations

Medicine, Oncology, Pharmacology +14

A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer

Laurent Zelek, Alejandro Yovine, Étienne Brain et al. · British Journal of Cancer · 2006 · 86 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase II study of elliptinium acetate salvage treatment of advanced breast cancer

Jacques Rouëssé, M. Spielmann, F Turpin et al. · European Journal of Cancer · 1993 · 54 citations

Medicine, Oncology, Pharmacotherapy +16

Hepatitis C virus infection and lymphoproliferative diseases in France: A national study

Pierre Hausfater, P. Cacoub, Éric Rosenthal et al. · American Journal of Hematology · 2000 · 43 citations

Medicine, Hematology, Infectious Diseases +12

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

M. Namer, P. Soler-Michel, F Turpin et al. · European Journal of Cancer · 2001 · 28 citations

Medicine, Oncology, Pharmacology +13